Dr. Shuliang Jiao received his Ph.D from the department of Biomedical Engineering of Texas A&M University in 2003. After graduation he joined the faculty of Bascom Palmer Eye Institute of University of Miami as an assistant professor and later the Department of Ophthalmology, Keck School of Medicine of University of Southern California as an associate professor. He moved to Florida International University in the Fall of 2012. He is currently a professor in the Department of Biomedical Engineering. His research interest is mainly focused on the development of innovative technologies for imaging and treatment of blinding eye diseases. His current research includes the technological development and application of Optical Coherence Tomography (OCT), Photoacoustic Microscopy, and Multimodal Functional Imaging for the early diagnosis and treatment monitoring of major blinding diseases like age related macular degeneration (AMD), diabetic retinopathy, and glaucoma. By the summer of 2018 he holds 7 patents, one of which was licensed to a leading ophthalmic technology development company, 3 patent applications, and several invention disclosures. His research has been continuously funded by the NIH through major research grants. He has also received funding from the department of defense, the Wallace Coulter Foundation, and the JDRF.